These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27606258)

  • 1. Preparation and evaluation of a novel oral delivery system for low molecular weight heparin.
    Lavanya N; Muzib YI; Aukunuru J; Balekari U
    Int J Pharm Investig; 2016; 6(3):148-57. PubMed ID: 27606258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin incorporating liposomes as a delivery system of heparin from PET-covered metallic stents: effect on haemocompatibility.
    Koromila G; Michanetzis GP; Missirlis YF; Antimisiaris SG
    Biomaterials; 2006 Apr; 27(12):2525-33. PubMed ID: 16410022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Chitosan-Coated Liposomes Coloaded with Exemestane and Genistein for an Effective Breast Cancer Therapy.
    Sharma S; Gupta P; Kawish SM; Ahmad S; Iqbal Z; Vohora D; Kohli K
    ACS Omega; 2024 Feb; 9(8):9735-9752. PubMed ID: 38434864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketoprofen-loaded Eudragit electrospun nanofibers for the treatment of oral mucositis.
    Reda RI; Wen MM; El-Kamel AH
    Int J Nanomedicine; 2017; 12():2335-2351. PubMed ID: 28392691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of PEG-PLGA based Intravenous Low Molecular Weight Heparin (LMWH) Nanoparticles Intended to Treat Venous Thrombosis.
    Jogala S; Rachamalla SS; Aukunuru J
    Curr Drug Deliv; 2016; 13(5):698-710. PubMed ID: 26777886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterization of polymer-coated liposomes for vaginal delivery of sildenafil citrate.
    Refai H; Hassan D; Abdelmonem R
    Drug Deliv; 2017 Nov; 24(1):278-288. PubMed ID: 28165805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of subcutaneous sustained release nanoparticles encapsulating low molecular weight heparin.
    Jogala S; Rachamalla SS; Aukunuru J
    J Adv Pharm Technol Res; 2015; 6(2):58-64. PubMed ID: 25878975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positively charged polyethylenimines enhance nasal absorption of the negatively charged drug, low molecular weight heparin.
    Yang T; Hussain A; Bai S; Khalil IA; Harashima H; Ahsan F
    J Control Release; 2006 Oct; 115(3):289-97. PubMed ID: 17023085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elastic liposomes bearing meloxicam-beta-cyclodextrin for transdermal delivery.
    Jain SK; Gupta Y; Jain A; Amin S
    Curr Drug Deliv; 2008 Jul; 5(3):207-14. PubMed ID: 18673264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of free mixed-film of pectin/chitosan/Eudragit RS intended for sigmoidal drug delivery.
    Ghaffari A; Navaee K; Oskoui M; Bayati K; Rafiee-Tehrani M
    Eur J Pharm Biopharm; 2007 Aug; 67(1):175-86. PubMed ID: 17346954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low molecular weight heparin-loaded polymeric nanoparticles: formulation, characterization, and release characteristics.
    Hoffart V; Ubrich N; Simonin C; Babak V; Vigneron C; Hoffman M; Lecompte T; Maincent P
    Drug Dev Ind Pharm; 2002 Oct; 28(9):1091-9. PubMed ID: 12455468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and evaluation of oral solid heparin using emulsifier and adsorbent for in vitro and in vivo studies.
    Ito Y; Kusawake T; Prasad YV; Sugioka N; Shibata N; Takada K
    Int J Pharm; 2006 Jul; 317(2):114-9. PubMed ID: 16631328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing the Intestinal Permeation of the Chondroprotective Nutraceuticals Glucosamine Sulphate and Chondroitin Sulphate Using Conventional and Modified Liposomes.
    Agiba AM; Nasr M; Abdel-Hamid S; Eldin AB; Geneidi AS
    Curr Drug Deliv; 2018; 15(6):907-916. PubMed ID: 29359666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation.
    Fan B; Xing Y; Zheng Y; Sun C; Liang G
    Drug Deliv; 2016; 23(1):238-47. PubMed ID: 24865290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buccal delivery of low molecular weight heparin by cationic polymethacrylate nanoparticles.
    Mouftah S; Abdel-Mottaleb MMA; Lamprecht A
    Int J Pharm; 2016 Dec; 515(1-2):565-574. PubMed ID: 27773855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral delivery of low molecular weight heparin microspheres prepared using biodegradable polymer matrix system.
    Lanke SS; Gayakwad SG; Strom JG; D'souza MJ
    J Microencapsul; 2009 Sep; 26(6):493-500. PubMed ID: 18846463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal Delivery of Ondansetron Hydrochloride via Bilosomal Systems: In Vitro, Ex Vivo, and In Vivo Characterization Studies.
    Ammar HO; Mohamed MI; Tadros MI; Fouly AA
    AAPS PharmSciTech; 2018 Jul; 19(5):2276-2287. PubMed ID: 29845503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation, evaluation, and pharmacokinetics of isradipine proliposomes for oral delivery.
    Bobbala SK; Veerareddy PR
    J Liposome Res; 2012 Dec; 22(4):285-94. PubMed ID: 22762199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and Characterization of Mucoadhesive Loratadine Nanoliposomes for Intranasal Administration.
    Tamaddon L; Mohamadi N; Bavarsad N
    Turk J Pharm Sci; 2021 Sep; 18(4):492-497. PubMed ID: 34496556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.